tiakis Biotech AG
PrivateLast Round
Series A
Oct 15, 2021
Company Overview
tiakis Biotech AG is a biotechnology company that develops anti-inflammatory and tissue-protective therapeutic drugs for pulmonary and cardiovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
tiakis Biotech AG Comparables
Compare tiakis Biotech AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cereno Scientific | 79% | |
| GSK plc | 75% | |
| Ono Pharmaceutical Co., Ltd. | 71% | |
tiakis Biotech AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 15, 2021 |
tiakis Biotech AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Elevat3 Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 2, 2026
Monthly visitors grew 308% MoM, reaching 1.6K.
tiakis Biotech AG Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about tiakis Biotech AG's valuation, stock price, and market status.